Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients
Clinical trial NCT03815474 · UNKNOWN
Trial details
- NCT number
- NCT03815474
- Sponsor
- Liaoning Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-20
- Primary completion
- 2019-12-31
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.